CannabisNewsWire
Editorial Coverage: The United States House passed the 2018 Farm Bill, which will redefine subsidies to
farmers, nutritional welfare recipients, conservationists and
others. Tucked into this bill of more than 1,000 pages is hemp
legalization legislation supported by Senate Majority Leader
Mitch McConnell. Demand – and thus farming revenue – for tobacco is
waning, and McConnell says hemp farming could help bolster farming
communities in his home state of Kentucky and across the country.
Currently listed as a controlled substance under federal law, the
new bill will declassify hemp as a schedule 1 drug and label it as
a viable agricultural commodity. Through its hempSMART™ subsidiary,
Marijuana Company of America, Inc. (OTC: MCOA) (MCOA
Profile) is one example of a few companies currently
providing consumers hemp plant-based products under the rubric of
existing laws, and the company has undertaken broad-based legal
hemp cultivation programs. Other companies that could feel the
ripples of change in the space are Isodiol International,
Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F), CV
Sciences, Inc. (OTC: CVSI), Medical Marijuana,
Inc. (OTC: MJNA), and Lexaria Bioscience Corp.
(CSE: LXX) (OTC: LXRP) (LXRP
Profile).
Hemp’s History
Archaeological evidence reveals that for over 10,000 years hemp
has been used by humans for pottery, shoes, ropes, clothing, food,
medicine, and a wide array of other applications. Since early
populations ingested hemp seeds, it stands to reason they also
discovered the medicinal properties found in the plant. Ancient
Asia, Egypt, India, Greece and the Islamic world all have rich
histories relating to medicinal cannabis. In the 19th century,
cannabinoids gained popularity for therapeutic use in Western
medicine, but regulatory efforts imposed strictures during the
20th Century, eventually leading to a ban on its use in
the U.S. under federal drug
controls because of hemp’s relation to its more
drug-user-friendly cannabis counterpart, marijuana. But, in recent
years, society has turned to modern science to substantiate
anecdotal claims about the therapeutic efficacy of non-psychoactive
cannabidiol (CBD) found in the hemp plant.
"I know there are farming communities all over the country who
are interested in this," McConnell told the Senate Agriculture
Committee amid debate over his bill. "Mine are particularly
interested in it, and the reason for that is — as all of you know —
our No. 1 cash crop used to be something that's really not good for
you: tobacco. And that has declined significantly, as it should,
given the public health concerns.”
The federal government has exhibited schizophrenic regulatory
tendencies toward hemp since the passage of the Marijuana Tax Act
of 1937 that quashed hemp production with exorbitant excise taxes.
Reversing course during WWII, the government
urged farmers to grow hemp for fiber and also waived taxes, and
over 400,000 acres of hemp were cultivated between 1942 and 1945.
After the war, hemp again had persona non grata status. Congress
then passed the Controlled Substances Act in 1970, prohibiting the
use of all cannabis for any purpose whatsoever and effectively
terminating all industrial hemp production. Hemp extracts, however,
are considered legal because they contain less than 0.3 percent
THC, but the cultivation of hemp remains federally verboten. Now,
the advancement of the Farm Bill signals a revived federal interest
in the industrial hemp industry.
Hemp Pioneers
Led by hemp industry pioneers, Marijuana
Company of America, Inc. (OTC: MCOA) has spearheaded efforts
and staked claims on multiple legal hemp cultivation projects. The
company’s innovative strategy is to vertically integrate hemp
production and sales – from seed to shelf. Cultivation of quality
hemp will feed MCOA’s innovative CBD-based formulations, which use
the highest-quality hemp to produce what could be the
finest-quality botanical supplements on the market. The hempSMART™
product line contains tested levels of clinically researched
ingredients to meet consumer needs that support the body’s natural
endocannabinoid system.
From seed to shelf, MCOA has built its business model around
industrial hemp-based CBD products. Hemp has a myriad of uses
beyond CBD therapeutics – as a food, a natural fiber, and even as a
commodity in the building materials sectors. No part of the plant
goes unused, and MCOA’s overarching strategy is to capitalize at
each profit point – from farm to finished products. MCOA appears to
be establishing a commanding presence at multiple inflection points
across the entire hemp value chain.
hempSMART™, Inc.
Expanding on ancestral wisdom, MCOA has combined the most
effective ingredients in wellness technologies with pure
plant-derived industrial hemp-based cannabinoids to create
optimally formulated wellness products for health-conscious
consumers.
hempSMART™ offers a number of different products within a wide
range of delivery systems, such as its capsule-based formulations
hempSMART™ Brain, a patent-pending nootropic product designed to
support natural brain function; and hempSMART™ Pain, which is
formulated with a blend of premium full-spectrum CBD and botanical
supplements designed for pain associated with physical
activity.
The company also offers sublingual CBD tinctures to customers
including hempSMART™ Full-Spectrum Drops and their natural pet
supplement hempSMART™ Pet Drops with advanced bioavailability.
hempSMART™ has also expanded upon its established line of
products by offering topical products such as hempSMART™ Pain
Cream, which is designed to provide temporary relief and soothe
sore, aching muscles and joints. The company also launched a new
cosmetic product, hempSMART™ Face, a CBD facial moisturizer that
has been designed to refresh, replenish and restore skin cells on
the face.
MCOA’s hempSMART™ CBD consumer products are sold at www.hempsmart.com.
Hemp Cultivation
In what appears to be a vertically integrated business strategy,
MCOA entered into a joint venture with Global Hemp Group Inc. (OTC:
GBHPF) to launch multiple industrial hemp cultivation projects in
the legal marijuana states of the U.S. and in Canada. The first is
a 125-acre industrial hemp cultivation project in northeast New
Brunswick. The project is well
under way with objectives of promoting hemp farming and
attendant year-round jobs.
A certified professional agronomist, Joan Parker-Duivenvoorden,
has been hired to manage the project. She has over 15 years of
experience with the Nova Scotia Department of Agriculture and with
the New Brunswick Soil and Crop Improvement Association, which will
prove invaluable as the project expands to encompass and employ
over 50 farmers.
Planting has been completed on the first 77 acres, and the
remaining 48 acres will be seeded soon. Drying equipment is being
evaluated to process the hemp after harvest, and management is
already in discussions with several potential processing partners
for extraction of cannabinoids. Once all the licenses have been
acquired for importing and manufacturing finished CBD products, the
New Brunswick site could easily serve as a distribution center for
MCOA’s hempSMART™ subsidiary.
In another joint venture with Global Hemp Group, MCOA is also
developing Covered Bridge Acres, a high-yielding CBD hemp
cultivation project in Oregon. Operations at the farm are well
under way. The project will utilize both traditional outdoor
cultivation and what will be over 19,296 square feet of
greenhouses.
“Our evolving project in Scio, Oregon, highlights the quality of
the team in place as they continue to lean on their many years of
experience cultivating hemp. Activities such as these will help to
secure the raw oil that we will need for our hempSMART brand of CBD
infused products,” stated Donald Steinberg, MCOA’s CEO.
The Takeaway
With rapidly expanding retail distribution and burgeoning,
diversified hemp cultivation programs underway, MCOA is fast
approaching the vertical integration that typically impacts bottom
lines and drives shareholder value.
Other companies already operating in the CBD space include:
Isodiol International (CSE: ISOL) (OTC: ISOLF) (FSE:
LB6A.F) grows and harvests hemp on an industrial scale and
then processes it to extract cannabidiol (CBD) for worldwide
distribution. The company pioneered the commercialization of 99
percent-plus pure, pharmaceutical-grade cannabinoids,
micro-encapsulations and nanotechnology for consumable and topical
skin care products.
CV Sciences (OTC: CVSI) operates in two
business segments. The company’s drug development division develops
and commercializes novel therapeutics utilizing synthetic CBD. Its
consumer product division manufactures, markets and sells
plant-based CBD products to a range of market sectors.
Medical Marijuana (OTC: MJNA) develops,
distributes and sells hemp oil that contains naturally occurring
cannabinoids, including CBD, and other products containing CBD oil.
The company sells its hemp-derived CBD products through its
distribution subsidiaries. The company was among the first to bring
hemp-based CBD oil products to market in the United States.
Lexaria
Bioscience Corp. (CSE: LXX) (OTC: LXRP) out-licenses
its patented delivery technology, which lowers dosing of lipophilic
active molecules and enhances their effectiveness. The company’s
technology increases intestinal absorption rates, speeds delivery
to the bloodstream, and masks tastes for orally administered
bioactive molecules including cannabinoids, vitamins, NSAIDs,
nicotine and other molecules.
Together, MCOA and these companies weave a tapestry of industry,
innovation and intuitive concern for the communities they serve
with nature-based hemp products that appear to be once again losing
the stigma that has come from being marijuana’s staider
sibling.
For more information on Marijuana Company of America, visit
Marijuana
Company of America, Inc. (OTC: MCOA)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides
(1) access to our news aggregation and syndication servers, (2)
CannabisNewsBreaks that summarize
corporate news and information, (3) enhanced press release
services, (4) social media distribution and optimization services,
and (5) a full array of corporate communication solutions. As a
multifaceted financial news and content distribution company with
an extensive team of contributing journalists and writers, CNW is
uniquely positioned to best serve private and public companies that
desire to reach a wide audience of investors, consumers,
journalists and the general public. CNW has an ever-growing
distribution network of more than 5,000 key syndication outlets
across the country. By cutting through the overload of information
in today’s market, CNW brings its clients unparalleled visibility,
recognition and brand awareness. CNW is where news, content and
information converge.
Receive Text Alerts
from CannabisNewsWire: Text "Cannabis" to
21000
For more information please visit https://www.CannabisNewsWire.com and
or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the
CannabisNewsWire website applicable to all content provided by CNW,
wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article
and content set forth above. References to any issuer other than
the profiled issuer are intended solely to identify industry
participants and do not constitute an endorsement of any issuer and
do not constitute a comparison to the profiled issuer. The
commentary, views and opinions expressed in this release by CNW are
solely those of CNW. Readers of this Article and content agree that
they cannot and will not seek to hold liable CNW for any investment
decisions by their readers or subscribers. CNW is a news
dissemination and financial marketing solutions provider and is NOT
registered broker-dealers/analysts/investment advisers, hold no
investment licenses and may NOT sell, offer to sell or offer to buy
any security.
The Article and content related to the profiled company
represent the personal and subjective views of the Author, and are
subject to change at any time without notice. The information
provided in the Article and the content has been obtained from
sources which the Author believes to be reliable. However, the
Author has not independently verified or otherwise investigated all
such information. None of the Author, CNW, or any of their
respective affiliates, guarantee the accuracy or completeness of
any such information. This Article and content are not, and should
not be regarded as investment advice or as a recommendation
regarding any particular security or course of action; readers are
strongly urged to speak with their own investment advisor and
review all of the profiled issuer’s filings made with the
Securities and Exchange Commission before making any investment
decisions and should understand the risks associated with an
investment in the profiled issuer’s securities, including, but not
limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E the Securities Exchange Act of 1934, as amended and
such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. “Forward-looking statements” describe future expectations,
plans, results, or strategies and are generally preceded by words
such as “may”, “future”, “plan” or “planned”, “will” or “should”,
“expected,” “anticipates”, “draft”, “eventually” or “projected”.
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks
identified in a company’s annual report on Form 10-K or 10-KSB and
other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this
release are made as of the date hereof and CNW undertakes no
obligation to update such statements.
Source:
CannabisNewsWire
Contact:
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net
Isodiol (CE) (USOTC:ISOLF)
Historical Stock Chart
From Nov 2024 to Dec 2024
Isodiol (CE) (USOTC:ISOLF)
Historical Stock Chart
From Dec 2023 to Dec 2024
